Brevinin-2CE

General Information


DRACP ID  DRACP03592

Peptide Name   Brevinin-2CE

Sequence  GLLSVFKGVLKTAGKNVAKNVAGSLLDQLKCKISGGC

Sequence Length  37

UniProt ID  F1AEM2  F1AEM1 

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03592

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C164H286N46O47S2

Absent amino acids  EHMPRWY

Common amino acids  GKL

Mass  436082

Pl  10.51

Basic residues  6

Acidic residues  1

Hydrophobic residues  15

Net charge  5

Boman Index  -640

Hydrophobicity  38.92

Aliphatic Index  113.24

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  125

Absorbance 280nm  3.47

Polar residues  14

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24474334

Title  In vitro synergistic activities of antimicrobial peptide brevinin-2CE with five kinds of antibiotics against multidrug-resistant clinical isolates

Doi Not available

Year  2014

Literature 2

Pubmed ID 21303203

Title  Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis

Doi Not available

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  8065

DRACP is developed by Dr.Zheng's team.